Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;101(4):824-825.
doi: 10.1016/j.kint.2022.01.016. Epub 2022 Feb 12.

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination

Adrien Flahault  1 , Justine Touchard  2 , Hélène Péré  3 , Laetitia Ulrich  4 , Brigitte Sabatier  2 , David Veyer  3 , David Lebeaux  5 , Eric Thervet  6
Affiliations

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination

Adrien Flahault et al. Kidney Int. 2022 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Occurrence of coronavirus disease 2019 (COVID-19) breakthrough infections is associated with the occurrence of the Omicron variant in Ile-de-France, France. Green dashed line: cumulative number of REGEN-Cov administrations. Red line: cumulative number of COVID-19 infections among patients treated with REGEN-Cov in our cohort. Black curve: COVID-19 incidence rate in Ile de France, France, per 100,000 inhabitants. Blue area: proportion of COVID-19 cases with the suspected Delta variant (the presence of the L452R mutation) in Ile-de-France, France. Pink area: proportion of COVID-19 cases with suspected Omicron variant (the lack of the L452R mutation) in Ile-de-France, France. Data for Ile de France were obtained from Santé Publique France (https://geodes.santepubliquefrance.fr) on January 22, 2022.
See this image and copyright information in PMC

References

    1. Ducloux D., Courivaud C. REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme. Kidney Int. 2022;101:645–646. - PMC - PubMed
    1. O’Brien M.P., Forleo-Neto E., Musser B.J., et al. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184–1195. - PMC - PubMed
    1. Planas D., Saunders N., Maes P., et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671–675. - PubMed
    1. Wilhelm A., Widera M., Grikscheit K., et al. Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies. medRxiv. https://doi.org/10.1101/2021.12.07.21267432 Published online December 8, 2021. - DOI

Substances